Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John V. Balen

John V. Balen is recorded as Chairman at Cardlytics, Inc. (CDLX). Cardlytics, Inc. reported in an 8-K filed January 2, 2024 that John V. Balen resigned as chairperson of the Board, as a member of the Board, as committee chairperson of the nominating and corporate governance committe, effective January 1, 2024. Cardlytics, Inc. reported in an 8-K filed July 10, 2023 that John V. Balen was appointed member of the Audit Committee, effective July 10, 2023. Cardlytics, Inc. reported in an 8-K filed November 14, 2022 that John V. Balen was appointed Board Chairman, effective November 12, 2022.

“On December 29, 2023, John V. Balen provided notice to the Board that he was resigning as chairperson of the Board, as a member of the Board, as committee chairperson of the nominating and corporate governance committee of the Board (the “Nominating and Corporate Governance Committee”), and as a member of the compensation committee of the Board, effective January 1, 2024.”
Cardlytics, Inc. Form 8-K, filed January 2, 2024 · Read the filing
“Also on July 7, 2023, the Board, with the recommendation of the Nominating and Corporate Governance Committee, appointed John V. Balen, who currently serves as the Chairman of the Board and has served on the Board since 2008, as a member of the Audit Committee, effective as of July 10, 2023.”
Cardlytics, Inc. Form 8-K, filed July 10, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cardlytics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.